The online home of Neurology Reviews

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

ICH survival lags in the community setting

Publish date:: March 17, 2020

Key clinical point: During 1991-2015, overall survival from intracerebral hemorrhage was poor and showed little change over time.

Major finding: The overall mortality at 6 months after an ICH was 64%.

Study details: The Rotterdam Study, a community-based, prospective observational study that enrolled 14,926 people starting in 1990.

Disclosures: The Rotterdam Study receives no commercial funding. Dr. Waziry had no disclosures.

Citation:

Waziry R et al. ISC 2020, Abstract LB14.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Stroke

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,

Hypertension often goes undertreated in patients with a history of stroke,

Higher stroke rates seen among patients with COVID-19 compared with influenza,

Updated AAN advisory outlines when PFO closure may be option for patients with stroke,

Silent brain infarcts found in 3% of AFib patients, tied to cognitive decline,